Alcoholic Hepatiti Drug Market
1 Study Coverage
1.1 Alcoholic Hepatiti Drug Product Introduction
1.2 Market by Type
1.2.1 Global Alcoholic Hepatiti Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 F-652
1.2.3 GRI-0621
1.2.4 HepaStem
1.2.5 IMM-124E
1.2.6 Others
1.3 Market by Application
1.3.1 Global Alcoholic Hepatiti Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Alcoholic Hepatiti Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Alcoholic Hepatiti Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Alcoholic Hepatiti Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Alcoholic Hepatiti Drug Sales by Region
2.4.1 Global Alcoholic Hepatiti Drug Sales by Region (2017-2022)
2.4.2 Global Sales Alcoholic Hepatiti Drug by Region (2023-2028)
2.5 Global Alcoholic Hepatiti Drug Revenue by Region
2.5.1 Global Alcoholic Hepatiti Drug Revenue by Region (2017-2022)
2.5.2 Global Alcoholic Hepatiti Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Alcoholic Hepatiti Drug Sales by Manufacturers
3.1.1 Global Top Alcoholic Hepatiti Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Alcoholic Hepatiti Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alcoholic Hepatiti Drug in 2021
3.2 Global Alcoholic Hepatiti Drug Revenue by Manufacturers
3.2.1 Global Alcoholic Hepatiti Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Alcoholic Hepatiti Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Alcoholic Hepatiti Drug Revenue in 2021
3.3 Global Alcoholic Hepatiti Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Alcoholic Hepatiti Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Alcoholic Hepatiti Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Alcoholic Hepatiti Drug Sales by Type
4.1.1 Global Alcoholic Hepatiti Drug Historical Sales by Type (2017-2022)
4.1.2 Global Alcoholic Hepatiti Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Alcoholic Hepatiti Drug Sales Market Share by Type (2017-2028)
4.2 Global Alcoholic Hepatiti Drug Revenue by Type
4.2.1 Global Alcoholic Hepatiti Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Alcoholic Hepatiti Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Alcoholic Hepatiti Drug Revenue Market Share by Type (2017-2028)
4.3 Global Alcoholic Hepatiti Drug Price by Type
4.3.1 Global Alcoholic Hepatiti Drug Price by Type (2017-2022)
4.3.2 Global Alcoholic Hepatiti Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Alcoholic Hepatiti Drug Sales by Application
5.1.1 Global Alcoholic Hepatiti Drug Historical Sales by Application (2017-2022)
5.1.2 Global Alcoholic Hepatiti Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Alcoholic Hepatiti Drug Sales Market Share by Application (2017-2028)
5.2 Global Alcoholic Hepatiti Drug Revenue by Application
5.2.1 Global Alcoholic Hepatiti Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Alcoholic Hepatiti Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Alcoholic Hepatiti Drug Revenue Market Share by Application (2017-2028)
5.3 Global Alcoholic Hepatiti Drug Price by Application
5.3.1 Global Alcoholic Hepatiti Drug Price by Application (2017-2022)
5.3.2 Global Alcoholic Hepatiti Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Alcoholic Hepatiti Drug Market Size by Type
6.1.1 North America Alcoholic Hepatiti Drug Sales by Type (2017-2028)
6.1.2 North America Alcoholic Hepatiti Drug Revenue by Type (2017-2028)
6.2 North America Alcoholic Hepatiti Drug Market Size by Application
6.2.1 North America Alcoholic Hepatiti Drug Sales by Application (2017-2028)
6.2.2 North America Alcoholic Hepatiti Drug Revenue by Application (2017-2028)
6.3 North America Alcoholic Hepatiti Drug Market Size by Country
6.3.1 North America Alcoholic Hepatiti Drug Sales by Country (2017-2028)
6.3.2 North America Alcoholic Hepatiti Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Alcoholic Hepatiti Drug Market Size by Type
7.1.1 Europe Alcoholic Hepatiti Drug Sales by Type (2017-2028)
7.1.2 Europe Alcoholic Hepatiti Drug Revenue by Type (2017-2028)
7.2 Europe Alcoholic Hepatiti Drug Market Size by Application
7.2.1 Europe Alcoholic Hepatiti Drug Sales by Application (2017-2028)
7.2.2 Europe Alcoholic Hepatiti Drug Revenue by Application (2017-2028)
7.3 Europe Alcoholic Hepatiti Drug Market Size by Country
7.3.1 Europe Alcoholic Hepatiti Drug Sales by Country (2017-2028)
7.3.2 Europe Alcoholic Hepatiti Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Alcoholic Hepatiti Drug Market Size by Type
8.1.1 Asia Pacific Alcoholic Hepatiti Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Alcoholic Hepatiti Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Alcoholic Hepatiti Drug Market Size by Application
8.2.1 Asia Pacific Alcoholic Hepatiti Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Alcoholic Hepatiti Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Alcoholic Hepatiti Drug Market Size by Region
8.3.1 Asia Pacific Alcoholic Hepatiti Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Alcoholic Hepatiti Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Alcoholic Hepatiti Drug Market Size by Type
9.1.1 Latin America Alcoholic Hepatiti Drug Sales by Type (2017-2028)
9.1.2 Latin America Alcoholic Hepatiti Drug Revenue by Type (2017-2028)
9.2 Latin America Alcoholic Hepatiti Drug Market Size by Application
9.2.1 Latin America Alcoholic Hepatiti Drug Sales by Application (2017-2028)
9.2.2 Latin America Alcoholic Hepatiti Drug Revenue by Application (2017-2028)
9.3 Latin America Alcoholic Hepatiti Drug Market Size by Country
9.3.1 Latin America Alcoholic Hepatiti Drug Sales by Country (2017-2028)
9.3.2 Latin America Alcoholic Hepatiti Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Alcoholic Hepatiti Drug Market Size by Type
10.1.1 Middle East and Africa Alcoholic Hepatiti Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Alcoholic Hepatiti Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Alcoholic Hepatiti Drug Market Size by Application
10.2.1 Middle East and Africa Alcoholic Hepatiti Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Alcoholic Hepatiti Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Alcoholic Hepatiti Drug Market Size by Country
10.3.1 Middle East and Africa Alcoholic Hepatiti Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Alcoholic Hepatiti Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Alfact Innovation
11.1.1 Alfact Innovation Corporation Information
11.1.2 Alfact Innovation Overview
11.1.3 Alfact Innovation Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Alfact Innovation Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alfact Innovation Recent Developments
11.2 Generon (Shanghai) Corp Ltd
11.2.1 Generon (Shanghai) Corp Ltd Corporation Information
11.2.2 Generon (Shanghai) Corp Ltd Overview
11.2.3 Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Generon (Shanghai) Corp Ltd Recent Developments
11.3 Gilead Sciences Inc
11.3.1 Gilead Sciences Inc Corporation Information
11.3.2 Gilead Sciences Inc Overview
11.3.3 Gilead Sciences Inc Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Gilead Sciences Inc Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Gilead Sciences Inc Recent Developments
11.4 GRI Bio Inc
11.4.1 GRI Bio Inc Corporation Information
11.4.2 GRI Bio Inc Overview
11.4.3 GRI Bio Inc Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GRI Bio Inc Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GRI Bio Inc Recent Developments
11.5 Immuron Ltd
11.5.1 Immuron Ltd Corporation Information
11.5.2 Immuron Ltd Overview
11.5.3 Immuron Ltd Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Immuron Ltd Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Immuron Ltd Recent Developments
11.6 Intercept Pharmaceuticals Inc
11.6.1 Intercept Pharmaceuticals Inc Corporation Information
11.6.2 Intercept Pharmaceuticals Inc Overview
11.6.3 Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Intercept Pharmaceuticals Inc Recent Developments
11.7 Promethera Biosciences SA
11.7.1 Promethera Biosciences SA Corporation Information
11.7.2 Promethera Biosciences SA Overview
11.7.3 Promethera Biosciences SA Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Promethera Biosciences SA Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Promethera Biosciences SA Recent Developments
11.8 Verlyx Pharma Inc
11.8.1 Verlyx Pharma Inc Corporation Information
11.8.2 Verlyx Pharma Inc Overview
11.8.3 Verlyx Pharma Inc Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Verlyx Pharma Inc Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Verlyx Pharma Inc Recent Developments
11.9 Vital Therapies Inc
11.9.1 Vital Therapies Inc Corporation Information
11.9.2 Vital Therapies Inc Overview
11.9.3 Vital Therapies Inc Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Vital Therapies Inc Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Vital Therapies Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Alcoholic Hepatiti Drug Industry Chain Analysis
12.2 Alcoholic Hepatiti Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Alcoholic Hepatiti Drug Production Mode & Process
12.4 Alcoholic Hepatiti Drug Sales and Marketing
12.4.1 Alcoholic Hepatiti Drug Sales Channels
12.4.2 Alcoholic Hepatiti Drug Distributors
12.5 Alcoholic Hepatiti Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Alcoholic Hepatiti Drug Industry Trends
13.2 Alcoholic Hepatiti Drug Market Drivers
13.3 Alcoholic Hepatiti Drug Market Challenges
13.4 Alcoholic Hepatiti Drug Market Restraints
14 Key Findings in The Global Alcoholic Hepatiti Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Alcoholic Hepatiti Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of F-652
Table 3. Major Manufacturers of GRI-0621
Table 4. Major Manufacturers of HepaStem
Table 5. Major Manufacturers of IMM-124E
Table 6. Major Manufacturers of Others
Table 7. Global Alcoholic Hepatiti Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Alcoholic Hepatiti Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Alcoholic Hepatiti Drug Sales by Region (2017-2022) & (K Pcs)
Table 10. Global Alcoholic Hepatiti Drug Sales Market Share by Region (2017-2022)
Table 11. Global Alcoholic Hepatiti Drug Sales by Region (2023-2028) & (K Pcs)
Table 12. Global Alcoholic Hepatiti Drug Sales Market Share by Region (2023-2028)
Table 13. Global Alcoholic Hepatiti Drug Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Alcoholic Hepatiti Drug Revenue Market Share by Region (2017-2022)
Table 15. Global Alcoholic Hepatiti Drug Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Alcoholic Hepatiti Drug Revenue Market Share by Region (2023-2028)
Table 17. Global Alcoholic Hepatiti Drug Sales by Manufacturers (2017-2022) & (K Pcs)
Table 18. Global Alcoholic Hepatiti Drug Sales Share by Manufacturers (2017-2022)
Table 19. Global Alcoholic Hepatiti Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Alcoholic Hepatiti Drug Revenue Share by Manufacturers (2017-2022)
Table 21. Alcoholic Hepatiti Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 22. Global Alcoholic Hepatiti Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Alcoholic Hepatiti Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alcoholic Hepatiti Drug as of 2021)
Table 24. Alcoholic Hepatiti Drug Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Alcoholic Hepatiti Drug Product Offered
Table 26. Date of Manufacturers Enter into Alcoholic Hepatiti Drug Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Alcoholic Hepatiti Drug Sales by Type (2017-2022) & (K Pcs)
Table 29. Global Alcoholic Hepatiti Drug Sales by Type (2023-2028) & (K Pcs)
Table 30. Global Alcoholic Hepatiti Drug Sales Share by Type (2017-2022)
Table 31. Global Alcoholic Hepatiti Drug Sales Share by Type (2023-2028)
Table 32. Global Alcoholic Hepatiti Drug Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Alcoholic Hepatiti Drug Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Alcoholic Hepatiti Drug Revenue Share by Type (2017-2022)
Table 35. Global Alcoholic Hepatiti Drug Revenue Share by Type (2023-2028)
Table 36. Alcoholic Hepatiti Drug Price by Type (2017-2022) & (USD/Pcs)
Table 37. Global Alcoholic Hepatiti Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 38. Global Alcoholic Hepatiti Drug Sales by Application (2017-2022) & (K Pcs)
Table 39. Global Alcoholic Hepatiti Drug Sales by Application (2023-2028) & (K Pcs)
Table 40. Global Alcoholic Hepatiti Drug Sales Share by Application (2017-2022)
Table 41. Global Alcoholic Hepatiti Drug Sales Share by Application (2023-2028)
Table 42. Global Alcoholic Hepatiti Drug Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Alcoholic Hepatiti Drug Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Alcoholic Hepatiti Drug Revenue Share by Application (2017-2022)
Table 45. Global Alcoholic Hepatiti Drug Revenue Share by Application (2023-2028)
Table 46. Alcoholic Hepatiti Drug Price by Application (2017-2022) & (USD/Pcs)
Table 47. Global Alcoholic Hepatiti Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 48. North America Alcoholic Hepatiti Drug Sales by Type (2017-2022) & (K Pcs)
Table 49. North America Alcoholic Hepatiti Drug Sales by Type (2023-2028) & (K Pcs)
Table 50. North America Alcoholic Hepatiti Drug Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Alcoholic Hepatiti Drug Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Alcoholic Hepatiti Drug Sales by Application (2017-2022) & (K Pcs)
Table 53. North America Alcoholic Hepatiti Drug Sales by Application (2023-2028) & (K Pcs)
Table 54. North America Alcoholic Hepatiti Drug Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Alcoholic Hepatiti Drug Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Alcoholic Hepatiti Drug Sales by Country (2017-2022) & (K Pcs)
Table 57. North America Alcoholic Hepatiti Drug Sales by Country (2023-2028) & (K Pcs)
Table 58. North America Alcoholic Hepatiti Drug Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Alcoholic Hepatiti Drug Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Alcoholic Hepatiti Drug Sales by Type (2017-2022) & (K Pcs)
Table 61. Europe Alcoholic Hepatiti Drug Sales by Type (2023-2028) & (K Pcs)
Table 62. Europe Alcoholic Hepatiti Drug Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Alcoholic Hepatiti Drug Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Alcoholic Hepatiti Drug Sales by Application (2017-2022) & (K Pcs)
Table 65. Europe Alcoholic Hepatiti Drug Sales by Application (2023-2028) & (K Pcs)
Table 66. Europe Alcoholic Hepatiti Drug Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Alcoholic Hepatiti Drug Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Alcoholic Hepatiti Drug Sales by Country (2017-2022) & (K Pcs)
Table 69. Europe Alcoholic Hepatiti Drug Sales by Country (2023-2028) & (K Pcs)
Table 70. Europe Alcoholic Hepatiti Drug Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Alcoholic Hepatiti Drug Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Alcoholic Hepatiti Drug Sales by Type (2017-2022) & (K Pcs)
Table 73. Asia Pacific Alcoholic Hepatiti Drug Sales by Type (2023-2028) & (K Pcs)
Table 74. Asia Pacific Alcoholic Hepatiti Drug Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Alcoholic Hepatiti Drug Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Alcoholic Hepatiti Drug Sales by Application (2017-2022) & (K Pcs)
Table 77. Asia Pacific Alcoholic Hepatiti Drug Sales by Application (2023-2028) & (K Pcs)
Table 78. Asia Pacific Alcoholic Hepatiti Drug Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Alcoholic Hepatiti Drug Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Alcoholic Hepatiti Drug Sales by Region (2017-2022) & (K Pcs)
Table 81. Asia Pacific Alcoholic Hepatiti Drug Sales by Region (2023-2028) & (K Pcs)
Table 82. Asia Pacific Alcoholic Hepatiti Drug Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Alcoholic Hepatiti Drug Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Alcoholic Hepatiti Drug Sales by Type (2017-2022) & (K Pcs)
Table 85. Latin America Alcoholic Hepatiti Drug Sales by Type (2023-2028) & (K Pcs)
Table 86. Latin America Alcoholic Hepatiti Drug Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Alcoholic Hepatiti Drug Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Alcoholic Hepatiti Drug Sales by Application (2017-2022) & (K Pcs)
Table 89. Latin America Alcoholic Hepatiti Drug Sales by Application (2023-2028) & (K Pcs)
Table 90. Latin America Alcoholic Hepatiti Drug Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Alcoholic Hepatiti Drug Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Alcoholic Hepatiti Drug Sales by Country (2017-2022) & (K Pcs)
Table 93. Latin America Alcoholic Hepatiti Drug Sales by Country (2023-2028) & (K Pcs)
Table 94. Latin America Alcoholic Hepatiti Drug Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Alcoholic Hepatiti Drug Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Alcoholic Hepatiti Drug Sales by Type (2017-2022) & (K Pcs)
Table 97. Middle East and Africa Alcoholic Hepatiti Drug Sales by Type (2023-2028) & (K Pcs)
Table 98. Middle East and Africa Alcoholic Hepatiti Drug Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Alcoholic Hepatiti Drug Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Alcoholic Hepatiti Drug Sales by Application (2017-2022) & (K Pcs)
Table 101. Middle East and Africa Alcoholic Hepatiti Drug Sales by Application (2023-2028) & (K Pcs)
Table 102. Middle East and Africa Alcoholic Hepatiti Drug Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Alcoholic Hepatiti Drug Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Alcoholic Hepatiti Drug Sales by Country (2017-2022) & (K Pcs)
Table 105. Middle East and Africa Alcoholic Hepatiti Drug Sales by Country (2023-2028) & (K Pcs)
Table 106. Middle East and Africa Alcoholic Hepatiti Drug Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Alcoholic Hepatiti Drug Revenue by Country (2023-2028) & (US$ Million)
Table 108. Alfact Innovation Corporation Information
Table 109. Alfact Innovation Description and Major Businesses
Table 110. Alfact Innovation Alcoholic Hepatiti Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 111. Alfact Innovation Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Alfact Innovation Recent Developments
Table 113. Generon (Shanghai) Corp Ltd Corporation Information
Table 114. Generon (Shanghai) Corp Ltd Description and Major Businesses
Table 115. Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 116. Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Generon (Shanghai) Corp Ltd Recent Developments
Table 118. Gilead Sciences Inc Corporation Information
Table 119. Gilead Sciences Inc Description and Major Businesses
Table 120. Gilead Sciences Inc Alcoholic Hepatiti Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 121. Gilead Sciences Inc Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Gilead Sciences Inc Recent Developments
Table 123. GRI Bio Inc Corporation Information
Table 124. GRI Bio Inc Description and Major Businesses
Table 125. GRI Bio Inc Alcoholic Hepatiti Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 126. GRI Bio Inc Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. GRI Bio Inc Recent Developments
Table 128. Immuron Ltd Corporation Information
Table 129. Immuron Ltd Description and Major Businesses
Table 130. Immuron Ltd Alcoholic Hepatiti Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 131. Immuron Ltd Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Immuron Ltd Recent Developments
Table 133. Intercept Pharmaceuticals Inc Corporation Information
Table 134. Intercept Pharmaceuticals Inc Description and Major Businesses
Table 135. Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 136. Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Intercept Pharmaceuticals Inc Recent Developments
Table 138. Promethera Biosciences SA Corporation Information
Table 139. Promethera Biosciences SA Description and Major Businesses
Table 140. Promethera Biosciences SA Alcoholic Hepatiti Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 141. Promethera Biosciences SA Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Promethera Biosciences SA Recent Developments
Table 143. Verlyx Pharma Inc Corporation Information
Table 144. Verlyx Pharma Inc Description and Major Businesses
Table 145. Verlyx Pharma Inc Alcoholic Hepatiti Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 146. Verlyx Pharma Inc Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Verlyx Pharma Inc Recent Developments
Table 148. Vital Therapies Inc Corporation Information
Table 149. Vital Therapies Inc Description and Major Businesses
Table 150. Vital Therapies Inc Alcoholic Hepatiti Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 151. Vital Therapies Inc Alcoholic Hepatiti Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Vital Therapies Inc Recent Developments
Table 153. Key Raw Materials Lists
Table 154. Raw Materials Key Suppliers Lists
Table 155. Alcoholic Hepatiti Drug Distributors List
Table 156. Alcoholic Hepatiti Drug Customers List
Table 157. Alcoholic Hepatiti Drug Market Trends
Table 158. Alcoholic Hepatiti Drug Market Drivers
Table 159. Alcoholic Hepatiti Drug Market Challenges
Table 160. Alcoholic Hepatiti Drug Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Alcoholic Hepatiti Drug Product Picture
Figure 3. Global Alcoholic Hepatiti Drug Market Share by Type in 2021 & 2028
Figure 3. F-652 Product Picture
Figure 4. GRI-0621 Product Picture
Figure 5. HepaStem Product Picture
Figure 6. IMM-124E Product Picture
Figure 7. Others Product Picture
Figure 8. Global Alcoholic Hepatiti Drug Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Alcoholic Hepatiti Drug Report Years Considered
Figure 13. Global Alcoholic Hepatiti Drug Sales 2017-2028 (K Pcs)
Figure 14. Global Alcoholic Hepatiti Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Alcoholic Hepatiti Drug Revenue 2017-2028 (US$ Million)
Figure 16. Global Alcoholic Hepatiti Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Alcoholic Hepatiti Drug Sales Market Share by Region (2017-2022)
Figure 18. Global Alcoholic Hepatiti Drug Sales Market Share by Region (2023-2028)
Figure 19. North America Alcoholic Hepatiti Drug Sales YoY (2017-2028) & (K Pcs)
Figure 20. North America Alcoholic Hepatiti Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Alcoholic Hepatiti Drug Sales YoY (2017-2028) & (K Pcs)
Figure 22. Europe Alcoholic Hepatiti Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Alcoholic Hepatiti Drug Sales YoY (2017-2028) & (K Pcs)
Figure 24. Asia-Pacific Alcoholic Hepatiti Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Alcoholic Hepatiti Drug Sales YoY (2017-2028) & (K Pcs)
Figure 26. Latin America Alcoholic Hepatiti Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Alcoholic Hepatiti Drug Sales YoY (2017-2028) & (K Pcs)
Figure 28. Middle East & Africa Alcoholic Hepatiti Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Alcoholic Hepatiti Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Alcoholic Hepatiti Drug in the World: Market Share by Alcoholic Hepatiti Drug Revenue in 2021
Figure 31. Global Alcoholic Hepatiti Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Alcoholic Hepatiti Drug Sales Market Share by Type (2017-2028)
Figure 33. Global Alcoholic Hepatiti Drug Revenue Market Share by Type (2017-2028)
Figure 34. Global Alcoholic Hepatiti Drug Sales Market Share by Application (2017-2028)
Figure 35. Global Alcoholic Hepatiti Drug Revenue Market Share by Application (2017-2028)
Figure 36. North America Alcoholic Hepatiti Drug Sales Market Share by Type (2017-2028)
Figure 37. North America Alcoholic Hepatiti Drug Revenue Market Share by Type (2017-2028)
Figure 38. North America Alcoholic Hepatiti Drug Sales Market Share by Application (2017-2028)
Figure 39. North America Alcoholic Hepatiti Drug Revenue Market Share by Application (2017-2028)
Figure 40. North America Alcoholic Hepatiti Drug Sales Share by Country (2017-2028)
Figure 41. North America Alcoholic Hepatiti Drug Revenue Share by Country (2017-2028)
Figure 42. U.S. Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Alcoholic Hepatiti Drug Sales Market Share by Type (2017-2028)
Figure 45. Europe Alcoholic Hepatiti Drug Revenue Market Share by Type (2017-2028)
Figure 46. Europe Alcoholic Hepatiti Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Alcoholic Hepatiti Drug Revenue Market Share by Application (2017-2028)
Figure 48. Europe Alcoholic Hepatiti Drug Sales Share by Country (2017-2028)
Figure 49. Europe Alcoholic Hepatiti Drug Revenue Share by Country (2017-2028)
Figure 50. Germany Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 51. France Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Alcoholic Hepatiti Drug Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Alcoholic Hepatiti Drug Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Alcoholic Hepatiti Drug Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Alcoholic Hepatiti Drug Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Alcoholic Hepatiti Drug Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Alcoholic Hepatiti Drug Revenue Share by Region (2017-2028)
Figure 61. China Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 64. India Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Alcoholic Hepatiti Drug Sales Market Share by Type (2017-2028)
Figure 72. Latin America Alcoholic Hepatiti Drug Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Alcoholic Hepatiti Drug Sales Market Share by Application (2017-2028)
Figure 74. Latin America Alcoholic Hepatiti Drug Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Alcoholic Hepatiti Drug Sales Share by Country (2017-2028)
Figure 76. Latin America Alcoholic Hepatiti Drug Revenue Share by Country (2017-2028)
Figure 77. Mexico Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 80. Colombia Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Alcoholic Hepatiti Drug Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Alcoholic Hepatiti Drug Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Alcoholic Hepatiti Drug Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Alcoholic Hepatiti Drug Revenue Share by Country (2017-2028)
Figure 87. Turkey Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 89. UAE Alcoholic Hepatiti Drug Revenue (2017-2028) & (US$ Million)
Figure 90. Alcoholic Hepatiti Drug Value Chain
Figure 91. Alcoholic Hepatiti Drug Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
Industry Market Size
